Rockbridge Investment Management, Lcc Gilead Sciences, Inc. Transaction History

Rockbridge Investment Management, Lcc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $73,270 - $83,090	-1,000 Closed	0 $0
Q2 2022 May 28, 2024	SELL	$57.72 - $65.01 $57,720 - $65,010	-1,000 Closed	0 $0
Q1 2022 May 28, 2024	BUY	$57.92 - $72.58 $57,920 - $72,580	1,000 New	1,000 $59,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $64,879 - $73,640	1,000 New	1,000 $73,000
Q1 2021 May 20, 2021	SELL	$60.0 - $68.46 $32,100 - $36,626	-535 Closed	0 $0
Q4 2020 Mar 04, 2021	BUY	$56.65 - $64.55 $21,300 - $24,270	376 Added 236.48%	535 $31,000
Q2 2020 Aug 20, 2020	BUY	$72.34 - $84.0 $11,502 - $13,356	159 New	159 $12,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.